YAHIRO Eiji

J-GLOBAL         Last updated: Nov 28, 2019 at 03:25
 
Avatar
Name
YAHIRO Eiji
Affiliation
Fukuoka University
Section
Faculty of Medicine, School of Medicine
Research funding number
70389360

Research Areas

 
 

Published Papers

 
Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Imaizumi S, Shiga Y, Ogawa M, Sako H, Nagata Y, Matsunaga A, Shirotani T, Hoshino F, Yahiro E, Uehara Y, Morito N, Tanigawa H, Shimono D, Fukushima M, Sugihara H, Norimatsu K, Kusumoto T, Saku K, Miura SI.
Heart Vessels.   34(4) 698-710   2019
Depressor effect of the young leaves of Polygonum hydropiper Linn. in high-salt induced hypertensive mice.
Devarajan S, Yahiro E, Uehara Y, Kuroda R, Hirano Y, Nagata K, Miura S, Saku K, Urata H.
Biomedicine & Pharmacotherapy   102 1182-1187   Jun 2018
心筋梗塞後の心不全発症患者は発ガン率が上昇する
八尋英二、朔啓二郎.
ModernPhysician   37(4) 404   2017
The Change in Body Weight During Hospitalization Predicts Mortality in Patients With Acute Decompensated Heart Failure.
Komaki T, Miura S, Arimura T, Shiga Y, Morii J, Kuwano T, Imaizumi S, Kitajima K, Iwata A, Morito N, Yahiro E, Fujimi K, Matsunaga A, Saku K.
J Clin Med Res   9(3) 200-206   2017
Effects of Tolvaptan With or Without the Pre-Administration of Renin-Angiotensin System Blockers in Hospitalized Patients With Acute Decompensated Heart Failure.
Adachi S, Miura S, Shiga Y, Arimura T, Morii J, Kuwano T, Kitajima K, Iwata A, Morito N, Fujimi K, Yahiro E, Nishikawa H, Saku K.
Int Heart J   58(3) 385-392   2017